Home/Ajax Therapeutics/David P. Steensma, MD, FACP

DP

David P. Steensma, MD, FACP

Chief Medical Officer

Ajax Therapeutics

Therapeutic Areas

Hematologic Cancers Myeloproliferative Neoplasms Myelofibrosis

Leadership Team at Ajax Therapeutics

Martin Vogelbaum

Chief Executive Officer, Co-founder

View full Ajax Therapeutics profile